Group 1 - The company, Guangzhou Jet Biofiltration Co., Ltd., will hold a half-year performance briefing on September 30, 2025, from 11:00 to 12:00 [2][5] - The briefing will take place at the Shanghai Stock Exchange Roadshow Center and will be conducted in an interactive online format [3][4] - Investors can submit questions for the briefing from September 23 to September 29, 2025, through the Roadshow Center website or via the company's email [6]

Group 1 - The company has elected Ms. Dannie Yuan as the employee representative director of the fourth board of directors, effective from the date of the employee representative assembly's approval until the end of the board's term [1][2][4] - The election of the employee representative director complies with relevant laws and regulations, ensuring that the number of directors who are also senior management and employee representatives does not exceed half of the total number of directors [2][4] - Ms. Dannie Yuan holds 21,000 shares in the company and has not faced any penalties from regulatory authorities, nor does she fall under any disqualifications as per the Company Law or the company's articles of association [4] Group 2 - The company held its second extraordinary general meeting of shareholders on September 16, 2025, with all procedures and attendance complying with the Company Law and the company's articles of association [5][7][11] - All resolutions presented at the meeting were approved, including amendments to the company's articles of association and the cancellation of the supervisory board [9][10][11] - The meeting was witnessed by legal representatives from Guangdong Guangxin Junda Law Firm, confirming the legality and validity of the meeting's proceedings and resolutions [11]

Core Viewpoint - The company announces the resignation of its board secretary, Ge Jingbo, due to personal reasons, and he will no longer hold any position within the company [2][3]. Group 1: Resignation Details - Ge Jingbo submitted a written resignation report to the board, which is effective upon delivery to the board [3]. - The company confirms that Ge Jingbo has completed the handover of his responsibilities, and his resignation will not affect the normal operations of the company [3]. Group 2: Impact on the Company - The company will promptly complete the selection of a new board secretary in accordance with relevant regulations and its articles of association [3]. - Until a new board secretary is appointed, the chairman, Yuan Jianhua, will act in this capacity [3]. - Ge Jingbo did not hold any shares in the company during his tenure and was recognized for his diligent work in governance, information disclosure, and investor relations [3].

通过天眼查大数据分析，广州洁特生物过滤股份有限公司共对外投资了14家企业，参与招投标项目182 次，知识产权方面有商标信息79条，专利信息266条，此外企业还拥有行政许可67个。 来源：金融界 金融界消息 截至2025年8月14日收盘，洁特生物（688026）报收于19.77元，下跌5.86%，换手率 5.92%，成交量8.30万手，成交金额1.68亿元。 资金流向方面，今日主力资金净流出3352.19万元，占比成交额19.96%。其中，超大单净流出1010.96万 元、占成交额6.02%，大单净流出2341.23万元、占成交额13.94%，中单净流出流入842.18万元、占成交 额5.02%，小单净流入2510.02万元、占成交额14.95%。 洁特生物最新一期业绩显示，截至2025一季报，公司营业总收入1.24亿元、同比增长26.00%，归属净利 润1646.23万元，同比增长101.29%，扣非净利润1564.92万元，同比增长269.23%，流动比率8.034、速动 比率6.628、资产负债率28.76%。 天眼查商业履历信息显示，广州洁特生物过滤股份有限公司，成立于2001年，位于广州市，是一家以从 ...

Core Viewpoint - The company has decided not to adjust the conversion price of its convertible bonds, despite triggering the downward adjustment clause due to stock price performance [2][7]. Group 1: Convertible Bond Details - The company issued 4.4 million convertible bonds at a face value of 100 RMB each, raising a total of 440 million RMB [3]. - The initial conversion price was set at 48.23 RMB per share, which was adjusted to 48.09 RMB on June 6, 2023, and further adjusted to 48.02 RMB on July 4, 2024, and to 47.95 RMB on July 2, 2025 [4]. - The downward adjustment clause is triggered when the stock price is below 85% of the conversion price for at least 15 out of 30 consecutive trading days [5]. Group 2: Board Decision - The board of directors convened on August 1, 2025, and unanimously agreed not to adjust the conversion price, with all related directors abstaining from the vote [8][9]. - The decision will remain in effect for three months, until November 1, 2025, during which time the company will not propose any downward adjustment even if the clause is triggered again [7][9].

Summary of Key Points Core Viewpoint - The announcement details the completion of a share reduction plan by a major shareholder of Guangzhou Jiete Biological Filtration Co., Ltd, indicating a strategic move in the company's ownership structure and potential implications for future governance and investment. Group 1: Shareholder Information - The shareholder, Guangzhou Luogang District Huizi Investment Management Partnership (Limited Partnership), held 1,396,950 shares, representing 1.00% of the company's total share capital prior to the reduction plan [2]. - The shares were acquired before the company's IPO and through capital reserve conversion, with the lock-up period lifted on January 30, 2023, allowing for trading [2]. Group 2: Reduction Plan Implementation - The shareholder planned to reduce holdings by up to 186,315 shares, which is 0.1327% of the total share capital, through centralized bidding [3]. - As of July 10, 2025, the shareholder successfully reduced their holdings by 186,315 shares, fully aligning with the previously disclosed reduction plan [3][4]. - The reduction was confirmed to have met the planned minimum reduction quantity, and the plan was not terminated early [4].

Summary of Key Points Core Viewpoint - The company has established a special account for the management and use of raised funds, ensuring investor protection and compliance with regulatory requirements [1][2][3]. Fundraising Basic Information - The company issued 4.4 million convertible bonds at a face value of 100 RMB each, raising a total of 440 million RMB, which has been verified by Tianjian Accounting Firm [1]. Special Account Establishment - A special account for raised funds has been set up to temporarily supplement working capital, with a limit of 200 million RMB, effective for up to 12 months from December 30, 2024 [2][3]. Three-Party Supervision Agreement - The company signed a three-party supervision agreement with the underwriter and the bank to regulate the management of raised funds, ensuring they are used solely for designated purposes [3][4]. Regulatory Compliance - The agreement aligns with relevant laws and regulations, including the Shanghai Stock Exchange's self-regulatory guidelines, to protect investor rights [4][5]. Monitoring and Reporting - The underwriter is responsible for ongoing supervision of the fund usage, including site investigations and documentation requests, to ensure compliance with the agreement [4][5].

Group 1 - The company's credit rating remains at A+ with a stable outlook for both the company and its convertible bonds [1][2] - The credit rating agency Zhongzheng Pengyuan conducted a follow-up credit rating for the company on June 26, 2025, confirming the ratings [2] - The previous credit rating was also A+ with a stable outlook, assessed on June 26, 2024 [1][2] Group 2 - The follow-up rating report was published on the Shanghai Stock Exchange website on the same day as the rating [2]

Core Viewpoint - The company, Guangzhou Jiete Biological Filtration Co., Ltd., is implementing a differentiated dividend distribution plan for the year 2024, which is based on the number of shares available after accounting for shares repurchased and held in a special account [1][2][5]. Group 1: Reasons for Differentiated Dividend - The differentiated dividend is a result of the company's decision to repurchase shares using its own or raised funds, with a total repurchase amount between RMB 20 million and RMB 40 million, and a maximum repurchase price of RMB 19.36 per share [1][2]. - The repurchased shares will not participate in profit distribution, leading to the need for a differentiated dividend distribution plan [2][3]. Group 2: Dividend Distribution Plan - The company plans to distribute a cash dividend of RMB 0.73 per 10 shares (including tax) to all shareholders based on the total share capital minus the repurchased shares [2][3]. - The actual number of shares participating in the distribution is 137,632,306 shares, calculated from the total share capital of 140,363,220 shares after deducting the repurchased shares [3][4]. Group 3: Calculation Basis for Differentiated Dividend - The cash dividend per share is calculated based on the adjusted total share capital, and the reference price for ex-dividend trading is determined using the formula: (previous closing price - cash dividend) / (1 + change in circulating shares ratio) [3][4]. - The impact of the differentiated dividend on the ex-dividend reference price is minimal, with an absolute value change of less than 1% [4]. Group 4: Verification Opinion - The sponsoring institution, Minsheng Securities, confirms that the differentiated dividend distribution complies with relevant laws and regulations, ensuring no harm to the interests of the company and all shareholders [5][6].

Core Viewpoint - The company announced an adjustment to the conversion price of its convertible bonds due to the implementation of the 2024 annual profit distribution plan, which includes a cash dividend of 0.73 yuan per 10 shares [1][2][4]. Summary by Sections Announcement of Adjustment - The conversion price of "洁特转债" will be adjusted from 48.02 yuan per share to 47.95 yuan per share, effective from July 2, 2025 [1][4]. - The trading of "洁特转债" will be suspended from June 24, 2025, until the equity registration date of July 1, 2025, and will resume on July 2, 2025 [1][4]. Basis for Adjustment - The adjustment is based on the resolution passed at the 2024 annual general meeting, which approved a cash dividend distribution of 0.73 yuan per 10 shares, with no stock increases or bonus shares [1][2][4]. - The total number of shares after excluding repurchased shares is 140,363,220, with 2,730,914 shares repurchased [4]. Calculation of Adjustment - The cash dividend per share is calculated as approximately 0.0716 yuan, leading to the new conversion price being calculated as follows: P1 = P0 - D, where P0 is the old conversion price and D is the cash dividend [4]. - The formula for adjusting the conversion price is provided, detailing how various corporate actions affect the conversion price [2][4]. Other Information - Investors seeking more details about "洁特转债" can refer to the company's prospectus published on June 24, 2022 [5].